Clinical Trial Update: Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated whether co-administration of mometasone or oxymetazoline with intranasal esketamine affects pharmacokinetics, safety, and tolerability…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Oxymetazoline nasal spray (oxymetazoline)
• Spravato (esketamine) (esketamine)
• mometasone nasal spray (mometasone)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Allergic Rhinitis | Phase 1 | Status: COMPLETED